カテゴリー： GlobalInfoResearch, 世界

経口抗糖尿病薬の世界市場：メーカー別、地域別、種類別、用途別、市場予測（～2024）

【英語タイトル】Global Oral Anti-Diabetic Drug Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

GlobalInfoResearchが出版した調査資料（GIR9100029）・商品コード：GIR9100029
・発行会社（調査会社）：GlobalInfoResearch
・発行日：2019年10月9日（※2024年版があります。お問い合わせください）
・ページ数：108
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール
・調査対象地域：グローバル
・産業分野：製薬・医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥515,040見積依頼/購入/質問フォーム
Multi User（10名様閲覧用）USD5,220 ⇒換算￥772,560見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,030,080見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
本調査レポートは、経口抗糖尿病薬の世界市場について調べ、まとめました。種類別セグメントは、グリメピリド、グリクラジド、グリブリド、その他等、用途別セグメントは、病院、研究機関等に区分しました。経口抗糖尿病薬の世界市場概観、メーカー動向、メーカー別経口抗糖尿病薬シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。
・経口抗糖尿病薬の市場概観
・経口抗糖尿病薬の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等）
・経口抗糖尿病薬の企業別販売動向、市場シェア、市場集中度、競争動向
・経口抗糖尿病薬の世界市場規模
・経口抗糖尿病薬の北米市場分析（アメリカ、カナダ、メキシコ等）
・経口抗糖尿病薬のアメリカ市場規模推移
・経口抗糖尿病薬のカナダ市場規模推移
・経口抗糖尿病薬のメキシコ市場規模推移
・経口抗糖尿病薬のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）
・経口抗糖尿病薬のドイツ市場規模推移
・経口抗糖尿病薬のイギリス市場規模推移
・経口抗糖尿病薬のロシア市場規模推移
・経口抗糖尿病薬のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等）
・経口抗糖尿病薬の日本市場規模推移
・経口抗糖尿病薬の中国市場規模推移
・経口抗糖尿病薬の韓国市場規模推移
・経口抗糖尿病薬のインド市場規模推移
・経口抗糖尿病薬の東南アジア市場規模推移
・経口抗糖尿病薬の南米市場分析（ブラジル、アルゼンチン等）
・経口抗糖尿病薬の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等）
・経口抗糖尿病薬の種類別分析/販売量、売上、市場シェア（グリメピリド、グリクラジド、グリブリド、その他）
・経口抗糖尿病薬の用途別分析/市場規模（病院、研究機関）
・経口抗糖尿病薬の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測）
・経口抗糖尿病薬の販売チャネル・代理店・貿易業者・ディーラー分析
【レポートの概要】

Scope of the Report:
The worldwide market for Oral Anti-Diabetic Drug is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Oral Anti-Diabetic Drug in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
Merck And Co.
AstraZeneca
Janssen Pharmaceuticals
Pfizer
Takeda
Eli Lilly
Novartis
Boehringer Ingelheim
Astellas
Bristol Myers Squibb
Sanofi
Abbott
Biocon

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Glimepiride
Gliclazide
Glyburide
Others

Market Segment by Applications, can be divided into
Hospital
Research Institual

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Oral Anti-Diabetic Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Oral Anti-Diabetic Drug, with price, sales, revenue and global market share of Oral Anti-Diabetic Drug in 2017 and 2018.
Chapter 3, the Oral Anti-Diabetic Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Oral Anti-Diabetic Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Oral Anti-Diabetic Drug market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Oral Anti-Diabetic Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.

【レポートの目次】

Table of Contents

1 Market Overview
1.1 Oral Anti-Diabetic Drug Introduction
1.2 Market Analysis by Type
1.2.1 Glimepiride
1.2.2 Gliclazide
1.2.3 Glyburide
1.2.4 Others
1.3 Market Analysis by Applications
1.3.1 Hospital
1.3.2 Research Institual
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Merck And Co.
2.1.1 Business Overview
2.1.2 Oral Anti-Diabetic Drug Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Merck And Co. Oral Anti-Diabetic Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 AstraZeneca
2.2.1 Business Overview
2.2.2 Oral Anti-Diabetic Drug Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 AstraZeneca Oral Anti-Diabetic Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 Janssen Pharmaceuticals
2.3.1 Business Overview
2.3.2 Oral Anti-Diabetic Drug Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Janssen Pharmaceuticals Oral Anti-Diabetic Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 Pfizer
2.4.1 Business Overview
2.4.2 Oral Anti-Diabetic Drug Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Pfizer Oral Anti-Diabetic Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 Takeda
2.5.1 Business Overview
2.5.2 Oral Anti-Diabetic Drug Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Takeda Oral Anti-Diabetic Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.6 Eli Lilly
2.6.1 Business Overview
2.6.2 Oral Anti-Diabetic Drug Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Eli Lilly Oral Anti-Diabetic Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.7 Novartis
2.7.1 Business Overview
2.7.2 Oral Anti-Diabetic Drug Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Novartis Oral Anti-Diabetic Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.8 Boehringer Ingelheim
2.8.1 Business Overview
2.8.2 Oral Anti-Diabetic Drug Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Boehringer Ingelheim Oral Anti-Diabetic Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.9 Astellas
2.9.1 Business Overview
2.9.2 Oral Anti-Diabetic Drug Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Astellas Oral Anti-Diabetic Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.10 Bristol Myers Squibb
2.10.1 Business Overview
2.10.2 Oral Anti-Diabetic Drug Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Bristol Myers Squibb Oral Anti-Diabetic Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.11 Sanofi
2.11.1 Business Overview
2.11.2 Oral Anti-Diabetic Drug Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Sanofi Oral Anti-Diabetic Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.12 Abbott
2.12.1 Business Overview
2.12.2 Oral Anti-Diabetic Drug Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Abbott Oral Anti-Diabetic Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.13 Biocon
2.13.1 Business Overview
2.13.2 Oral Anti-Diabetic Drug Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Biocon Oral Anti-Diabetic Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Oral Anti-Diabetic Drug Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Oral Anti-Diabetic Drug Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Oral Anti-Diabetic Drug Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Oral Anti-Diabetic Drug Manufacturer Market Share in 2018
3.3.2 Top 6 Oral Anti-Diabetic Drug Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Oral Anti-Diabetic Drug Market Analysis by Regions
4.1 Global Oral Anti-Diabetic Drug Sales, Revenue and Market Share by Regions
4.1.1 Global Oral Anti-Diabetic Drug Sales and Market Share by Regions (2014-2019)
4.1.2 Global Oral Anti-Diabetic Drug Revenue and Market Share by Regions (2014-2019)
4.2 North America Oral Anti-Diabetic Drug Sales and Growth Rate (2014-2019)
4.3 Europe Oral Anti-Diabetic Drug Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Oral Anti-Diabetic Drug Sales and Growth Rate (2014-2019)
4.5 South America Oral Anti-Diabetic Drug Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Oral Anti-Diabetic Drug Sales and Growth Rate (2014-2019)
5 North America Oral Anti-Diabetic Drug by Country
5.1 North America Oral Anti-Diabetic Drug Sales, Revenue and Market Share by Country
5.1.1 North America Oral Anti-Diabetic Drug Sales and Market Share by Country (2014-2019)
5.1.2 North America Oral Anti-Diabetic Drug Revenue and Market Share by Country (2014-2019)
5.2 United States Oral Anti-Diabetic Drug Sales and Growth Rate (2014-2019)
5.3 Canada Oral Anti-Diabetic Drug Sales and Growth Rate (2014-2019)
5.4 Mexico Oral Anti-Diabetic Drug Sales and Growth Rate (2014-2019)
6 Europe Oral Anti-Diabetic Drug by Country
6.1 Europe Oral Anti-Diabetic Drug Sales, Revenue and Market Share by Country
6.1.1 Europe Oral Anti-Diabetic Drug Sales and Market Share by Country (2014-2019)
6.1.2 Europe Oral Anti-Diabetic Drug Revenue and Market Share by Country (2014-2019)
6.2 Germany Oral Anti-Diabetic Drug Sales and Growth Rate (2014-2019)
6.3 UK Oral Anti-Diabetic Drug Sales and Growth Rate (2014-2019)
6.4 France Oral Anti-Diabetic Drug Sales and Growth Rate (2014-2019)
6.5 Russia Oral Anti-Diabetic Drug Sales and Growth Rate (2014-2019)
6.6 Italy Oral Anti-Diabetic Drug Sales and Growth Rate (2014-2019)
7 Asia-Pacific Oral Anti-Diabetic Drug by Country
7.1 Asia-Pacific Oral Anti-Diabetic Drug Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Oral Anti-Diabetic Drug Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Oral Anti-Diabetic Drug Revenue and Market Share by Country (2014-2019)
7.2 China Oral Anti-Diabetic Drug Sales and Growth Rate (2014-2019)
7.3 Japan Oral Anti-Diabetic Drug Sales and Growth Rate (2014-2019)
7.4 Korea Oral Anti-Diabetic Drug Sales and Growth Rate (2014-2019)
7.5 India Oral Anti-Diabetic Drug Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Oral Anti-Diabetic Drug Sales and Growth Rate (2014-2019)
8 South America Oral Anti-Diabetic Drug by Country
8.1 South America Oral Anti-Diabetic Drug Sales, Revenue and Market Share by Country
8.1.1 South America Oral Anti-Diabetic Drug Sales and Market Share by Country (2014-2019)
8.1.2 South America Oral Anti-Diabetic Drug Revenue and Market Share by Country (2014-2019)
8.2 Brazil Oral Anti-Diabetic Drug Sales and Growth Rate (2014-2019)
8.3 Argentina Oral Anti-Diabetic Drug Sales and Growth Rate (2014-2019)
8.4 Colombia Oral Anti-Diabetic Drug Sales and Growth Rate (2014-2019)
9 Middle East and Africa Oral Anti-Diabetic Drug by Countries
9.1 Middle East and Africa Oral Anti-Diabetic Drug Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Oral Anti-Diabetic Drug Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Oral Anti-Diabetic Drug Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Oral Anti-Diabetic Drug Sales and Growth Rate (2014-2019)
9.3 Turkey Oral Anti-Diabetic Drug Sales and Growth Rate (2014-2019)
9.4 Egypt Oral Anti-Diabetic Drug Sales and Growth Rate (2014-2019)
9.5 Nigeria Oral Anti-Diabetic Drug Sales and Growth Rate (2014-2019)
9.6 South Africa Oral Anti-Diabetic Drug Sales and Growth Rate (2014-2019)
10 Global Oral Anti-Diabetic Drug Market Segment by Type
10.1 Global Oral Anti-Diabetic Drug Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Oral Anti-Diabetic Drug Sales and Market Share by Type (2014-2019)
10.1.2 Global Oral Anti-Diabetic Drug Revenue and Market Share by Type (2014-2019)
10.2 Glimepiride Sales Growth and Price
10.2.1 Global Glimepiride Sales Growth (2014-2019)
10.2.2 Global Glimepiride Price (2014-2019)
10.3 Gliclazide Sales Growth and Price
10.3.1 Global Gliclazide Sales Growth (2014-2019)
10.3.2 Global Gliclazide Price (2014-2019)
10.4 Glyburide Sales Growth and Price
10.4.1 Global Glyburide Sales Growth (2014-2019)
10.4.2 Global Glyburide Price (2014-2019)
10.5 Others Sales Growth and Price
10.5.1 Global Others Sales Growth (2014-2019)
10.5.2 Global Others Price (2014-2019)
11 Global Oral Anti-Diabetic Drug Market Segment by Application
11.1 Global Oral Anti-Diabetic Drug Sales Market Share by Application (2014-2019)
11.2 Hospital Sales Growth (2014-2019)
11.3 Research Institual Sales Growth (2014-2019)
12 Oral Anti-Diabetic Drug Market Forecast (2019-2024)
12.1 Global Oral Anti-Diabetic Drug Sales, Revenue and Growth Rate (2019-2024)
12.2 Oral Anti-Diabetic Drug Market Forecast by Regions (2019-2024)
12.2.1 North America Oral Anti-Diabetic Drug Market Forecast (2019-2024)
12.2.2 Europe Oral Anti-Diabetic Drug Market Forecast (2019-2024)
12.2.3 Asia-Pacific Oral Anti-Diabetic Drug Market Forecast (2019-2024)
12.2.4 South America Oral Anti-Diabetic Drug Market Forecast (2019-2024)
12.2.5 Middle East and Africa Oral Anti-Diabetic Drug Market Forecast (2019-2024)
12.3 Oral Anti-Diabetic Drug Market Forecast by Type (2019-2024)
12.3.1 Global Oral Anti-Diabetic Drug Sales Forecast by Type (2019-2024)
12.3.2 Global Oral Anti-Diabetic Drug Market Share Forecast by Type (2019-2024)
12.4 Oral Anti-Diabetic Drug Market Forecast by Application (2019-2024)
12.4.1 Global Oral Anti-Diabetic Drug Sales Forecast by Application (2019-2024)
12.4.2 Global Oral Anti-Diabetic Drug Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source

List of Tables and Figures

Figure Oral Anti-Diabetic Drug Picture
Table Product Specifications of Oral Anti-Diabetic Drug
Figure Global Sales Market Share of Oral Anti-Diabetic Drug by Types in 2018
Table Oral Anti-Diabetic Drug Types for Major Manufacturers
Figure Glimepiride Picture
Figure Gliclazide Picture
Figure Glyburide Picture
Figure Others Picture
Figure Oral Anti-Diabetic Drug Sales Market Share by Applications in 2018
Figure Hospital Picture
Figure Research Institual Picture
Figure United States Oral Anti-Diabetic Drug Revenue (Value) and Growth Rate (2014-2024)
Figure Canada Oral Anti-Diabetic Drug Revenue (Value) and Growth Rate (2014-2024)
Figure Mexico Oral Anti-Diabetic Drug Revenue (Value) and Growth Rate (2014-2024)
Figure Germany Oral Anti-Diabetic Drug Revenue (Value) and Growth Rate (2014-2024)
Figure France Oral Anti-Diabetic Drug Revenue (Value) and Growth Rate (2014-2024)
Figure UK Oral Anti-Diabetic Drug Revenue (Value) and Growth Rate (2014-2024)
Figure Russia Oral Anti-Diabetic Drug Revenue (Value) and Growth Rate (2014-2024)
Figure Italy Oral Anti-Diabetic Drug Revenue (Value) and Growth Rate (2014-2024)
Figure China Oral Anti-Diabetic Drug Revenue (Value) and Growth Rate (2014-2024)
Figure Japan Oral Anti-Diabetic Drug Revenue (Value) and Growth Rate (2014-2024)
Figure Korea Oral Anti-Diabetic Drug Revenue (Value) and Growth Rate (2014-2024)
Figure India Oral Anti-Diabetic Drug Revenue (Value) and Growth Rate (2014-2024)
Figure Southeast Asia Oral Anti-Diabetic Drug Revenue (Value) and Growth Rate (2014-2024)
Figure Brazil Oral Anti-Diabetic Drug Revenue (Value) and Growth Rate (2014-2024)
Figure Egypt Oral Anti-Diabetic Drug Revenue (Value) and Growth Rate (2014-2024)
Figure Saudi Arabia Oral Anti-Diabetic Drug Revenue (Value) and Growth Rate (2014-2024)
Figure South Africa Oral Anti-Diabetic Drug Revenue (Value) and Growth Rate (2014-2024)
Figure Nigeria Oral Anti-Diabetic Drug Revenue (Value) and Growth Rate (2014-2024)
Table Merck And Co. Basic Information, Manufacturing Base and Competitors
Table Merck And Co. Oral Anti-Diabetic Drug Type and Applications
Table Merck And Co. Oral Anti-Diabetic Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table AstraZeneca Basic Information, Manufacturing Base and Competitors
Table AstraZeneca Oral Anti-Diabetic Drug Type and Applications
Table AstraZeneca Oral Anti-Diabetic Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Janssen Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Janssen Pharmaceuticals Oral Anti-Diabetic Drug Type and Applications
Table Janssen Pharmaceuticals Oral Anti-Diabetic Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Oral Anti-Diabetic Drug Type and Applications
Table Pfizer Oral Anti-Diabetic Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Takeda Basic Information, Manufacturing Base and Competitors
Table Takeda Oral Anti-Diabetic Drug Type and Applications
Table Takeda Oral Anti-Diabetic Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Eli Lilly Basic Information, Manufacturing Base and Competitors
Table Eli Lilly Oral Anti-Diabetic Drug Type and Applications
Table Eli Lilly Oral Anti-Diabetic Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Oral Anti-Diabetic Drug Type and Applications
Table Novartis Oral Anti-Diabetic Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table Boehringer Ingelheim Oral Anti-Diabetic Drug Type and Applications
Table Boehringer Ingelheim Oral Anti-Diabetic Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Astellas Basic Information, Manufacturing Base and Competitors
Table Astellas Oral Anti-Diabetic Drug Type and Applications
Table Astellas Oral Anti-Diabetic Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Bristol Myers Squibb Basic Information, Manufacturing Base and Competitors
Table Bristol Myers Squibb Oral Anti-Diabetic Drug Type and Applications
Table Bristol Myers Squibb Oral Anti-Diabetic Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Sanofi Basic Information, Manufacturing Base and Competitors
Table Sanofi Oral Anti-Diabetic Drug Type and Applications
Table Sanofi Oral Anti-Diabetic Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Abbott Basic Information, Manufacturing Base and Competitors
Table Abbott Oral Anti-Diabetic Drug Type and Applications
Table Abbott Oral Anti-Diabetic Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Biocon Basic Information, Manufacturing Base and Competitors
Table Biocon Oral Anti-Diabetic Drug Type and Applications
Table Biocon Oral Anti-Diabetic Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Global Oral Anti-Diabetic Drug Sales by Manufacturer (2017-2018)
Figure Global Oral Anti-Diabetic Drug Sales Market Share by Manufacturer in 2017
Figure Global Oral Anti-Diabetic Drug Sales Market Share by Manufacturer in 2018
Table Global Oral Anti-Diabetic Drug Revenue by Manufacturer (2017-2018)
Figure Global Oral Anti-Diabetic Drug Revenue Market Share by Manufacturer in 2017
Figure Global Oral Anti-Diabetic Drug Revenue Market Share by Manufacturer in 2018
Figure Top 3 Oral Anti-Diabetic Drug Manufacturer (Revenue) Market Share in 2018
Figure Top 6 Oral Anti-Diabetic Drug Manufacturer (Revenue) Market Share in 2018
Figure Global Oral Anti-Diabetic Drug Sales and Growth Rate (2014-2019)
Figure Global Oral Anti-Diabetic Drug Revenue and Growth Rate (2014-2019)
Table Global Oral Anti-Diabetic Drug Sales by Regions (2014-2019)
Table Global Oral Anti-Diabetic Drug Sales Market Share by Regions (2014-2019)
Table Global Oral Anti-Diabetic Drug Revenue by Regions (2014-2019)
Figure Global Oral Anti-Diabetic Drug Revenue Market Share by Regions (2014-2019)
Figure Global Oral Anti-Diabetic Drug Revenue Market Share by Regions in 2018
Figure North America Oral Anti-Diabetic Drug Sales and Growth Rate (2014-2019)
Figure Europe Oral Anti-Diabetic Drug Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Oral Anti-Diabetic Drug Sales and Growth Rate (2014-2019)
Figure South America Oral Anti-Diabetic Drug Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Oral Anti-Diabetic Drug Sales and Growth Rate (2014-2019)
Figure North America Oral Anti-Diabetic Drug Revenue and Growth Rate (2014-2019)
Table North America Oral Anti-Diabetic Drug Sales by Countries (2014-2019)
Table North America Oral Anti-Diabetic Drug Sales Market Share by Countries (2014-2019)
Figure North America Oral Anti-Diabetic Drug Sales Market Share by Countries (2014-2019)
Figure North America Oral Anti-Diabetic Drug Sales Market Share by Countries in 2018
Table North America Oral Anti-Diabetic Drug Revenue by Countries (2014-2019)
Table North America Oral Anti-Diabetic Drug Revenue Market Share by Countries (2014-2019)
Figure North America Oral Anti-Diabetic Drug Revenue Market Share by Countries (2014-2019)
Figure North America Oral Anti-Diabetic Drug Revenue Market Share by Countries in 2018
Figure United States Oral Anti-Diabetic Drug Sales and Growth Rate (2014-2019)
Figure Canada Oral Anti-Diabetic Drug Sales and Growth Rate (2014-2019)
Figure Mexico Oral Anti-Diabetic Drug Sales and Growth Rate (2014-2019)
Figure Europe Oral Anti-Diabetic Drug Revenue and Growth Rate (2014-2019)
Table Europe Oral Anti-Diabetic Drug Sales by Countries (2014-2019)
Table Europe Oral Anti-Diabetic Drug Sales Market Share by Countries (2014-2019)
Table Europe Oral Anti-Diabetic Drug Revenue by Countries (2014-2019)
Figure Europe Oral Anti-Diabetic Drug Revenue Market Share by Countries (2014-2019)
Figure Europe Oral Anti-Diabetic Drug Revenue Market Share by Countries in 2018
Figure Germany Oral Anti-Diabetic Drug Sales and Growth Rate (2014-2019)
Figure UK Oral Anti-Diabetic Drug Sales and Growth Rate (2014-2019)
Figure France Oral Anti-Diabetic Drug Sales and Growth Rate (2014-2019)
Figure Russia Oral Anti-Diabetic Drug Sales and Growth Rate (2014-2019)
Figure Italy Oral Anti-Diabetic Drug Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Oral Anti-Diabetic Drug Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Oral Anti-Diabetic Drug Sales by Countries (2014-2019)
Table Asia-Pacific Oral Anti-Diabetic Drug Sales Market Share by Countries (2014-2019)
Figure Asia-Pacific Oral Anti-Diabetic Drug Sales Market Share by Countries 2018
Table Asia-Pacific Oral Anti-Diabetic Drug Revenue by Countries (2014-2019)
Figure Asia-Pacific Oral Anti-Diabetic Drug Revenue Market Share by Countries 2018
Figure China Oral Anti-Diabetic Drug Sales and Growth Rate (2014-2019)
Figure Japan Oral Anti-Diabetic Drug Sales and Growth Rate (2014-2019)
Figure Korea Oral Anti-Diabetic Drug Sales and Growth Rate (2014-2019)
Figure India Oral Anti-Diabetic Drug Sales and Growth Rate (2014-2019)
Figure Southeast Asia Oral Anti-Diabetic Drug Sales and Growth Rate (2014-2019)
Figure South America Oral Anti-Diabetic Drug Revenue and Growth Rate (2014-2019)
Table South America Oral Anti-Diabetic Drug Sales by Countries (2014-2019)
Table South America Oral Anti-Diabetic Drug Sales Market Share by Countries (2014-2019)
Figure South America Oral Anti-Diabetic Drug Sales Market Share by Countries in 2018
Table South America Oral Anti-Diabetic Drug Revenue by Countries (2014-2019)
Table South America Oral Anti-Diabetic Drug Revenue Market Share by Countries (2014-2019)
Figure South America Oral Anti-Diabetic Drug Revenue Market Share by Countries in 2018
Figure Brazil Oral Anti-Diabetic Drug Sales and Growth Rate (2014-2019)
Figure Argentina Oral Anti-Diabetic Drug Sales and Growth Rate (2014-2019)
Figure Colombia Oral Anti-Diabetic Drug Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Oral Anti-Diabetic Drug Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Oral Anti-Diabetic Drug Sales by Countries (2014-2019)
Table Middle East and Africa Oral Anti-Diabetic Drug Sales Market Share by Countries (2014-2019)
Figure Middle East and Africa Oral Anti-Diabetic Drug Sales Market Share by Countries in 2018
Table Middle East and Africa Oral Anti-Diabetic Drug Revenue by Countries (2014-2019)
Table Middle East and Africa Oral Anti-Diabetic Drug Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Oral Anti-Diabetic Drug Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Oral Anti-Diabetic Drug Revenue Market Share by Countries in 2018
Figure Saudi Arabia Oral Anti-Diabetic Drug Sales and Growth Rate (2014-2019)
Figure UAE Oral Anti-Diabetic Drug Sales and Growth Rate (2014-2019)
Figure Egypt Oral Anti-Diabetic Drug Sales and Growth Rate (2014-2019)
Figure Nigeria Oral Anti-Diabetic Drug Sales and Growth Rate (2014-2019)
Figure South Africa Oral Anti-Diabetic Drug Sales and Growth Rate (2014-2019)
Table Global Oral Anti-Diabetic Drug Sales by Type (2014-2019)
Table Global Oral Anti-Diabetic Drug Sales Share by Type (2014-2019)
Table Global Oral Anti-Diabetic Drug Revenue by Type (2014-2019)
Table Global Oral Anti-Diabetic Drug Revenue Share by Type (2014-2019)
Figure Global Glimepiride Sales Growth (2014-2019)
Figure Global Glimepiride Price (2014-2019)
Figure Global Gliclazide Sales Growth (2014-2019)
Figure Global Gliclazide Price (2014-2019)
Figure Global Glyburide Sales Growth (2014-2019)
Figure Global Glyburide Price (2014-2019)
Figure Global Others Sales Growth (2014-2019)
Figure Global Others Price (2014-2019)
Table Global Oral Anti-Diabetic Drug Sales by Application (2014-2019)
Table Global Oral Anti-Diabetic Drug Sales Share by Application (2014-2019)
Figure Global Hospital Sales Growth (2014-2019)
Figure Global Research Institual Sales Growth (2014-2019)
Figure Global Oral Anti-Diabetic Drug Sales, Revenue and Growth Rate (2019-2024)
Table Global Oral Anti-Diabetic Drug Sales Forecast by Regions (2019-2024)
Table Global Oral Anti-Diabetic Drug Market Share Forecast by Regions (2019-2024)
Figure North America Sales Oral Anti-Diabetic Drug Market Forecast (2019-2024)
Figure Europe Sales Oral Anti-Diabetic Drug Market Forecast (2019-2024)
Figure Asia-Pacific Sales Oral Anti-Diabetic Drug Market Forecast (2019-2024)
Figure South America Sales Oral Anti-Diabetic Drug Market Forecast (2019-2024)
Figure Middle East and Africa Sales Oral Anti-Diabetic Drug Market Forecast (2019-2024)
Table Global Oral Anti-Diabetic Drug Sales Forecast by Type (2019-2024)
Table Global Oral Anti-Diabetic Drug Market Share Forecast by Type (2019-2024)
Table Global Oral Anti-Diabetic Drug Sales Forecast by Application (2019-2024)
Table Global Oral Anti-Diabetic Drug Market Share Forecast by Application (2019-2024)
Table Distributors/Traders/ Dealers List


【掲載企業】

Merck And Co.、 AstraZeneca、 Janssen Pharmaceuticals、 Pfizer、 Takeda、 Eli Lilly、 Novartis、 Boehringer Ingelheim、 Astellas、 Bristol Myers Squibb、 Sanofi、 Abbott、 Biocon

★調査レポート[経口抗糖尿病薬の世界市場：メーカー別、地域別、種類別、用途別、市場予測（～2024）] (コード：GIR9100029)販売に関する免責事項を必ずご確認ください。
★調査レポート[経口抗糖尿病薬の世界市場：メーカー別、地域別、種類別、用途別、市場予測（～2024）]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 皮膚潰瘍抗感染薬の世界市場：メーカー別、地域別、種類別、用途別、市場予測（～2024）
    GIR9101438 / GlobalInfoResearch / 2019年9月11日 / 本調査レポートは、皮膚潰瘍抗感染薬の世界市場について調べ、まとめました。種類別セグメントは、褥瘡、糖尿病性潰瘍、静脈性潰瘍、動脈性潰瘍等、用途別セグメントは、病院、診療所、その他等に区分しました。皮膚潰瘍抗感染薬の世界市場概観、メーカー動向、メーカー別皮膚潰瘍抗感染薬シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・皮膚潰瘍抗感染薬の市場概観 ・皮膚潰瘍抗感染薬の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・皮膚潰瘍抗感染薬の企業別販売動向、市場シェア、市場集中度、競争動向 ・皮膚潰瘍抗感染薬の世界市場規模 ・皮膚潰瘍抗感染薬の北米市場分析（アメリカ、カナダ、メキシコ等） ・皮膚潰瘍抗感染薬のアメリカ市場規模推移 ・皮膚潰瘍抗感染薬のカナダ市場規模推移 ・皮膚潰瘍抗感染薬のメキシコ市場規模推移 ・皮膚潰瘍抗感染薬のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...Wound Care Markets Volume I: Skin Ulcers, strong growth in newer technologies has been the main driver of increased revenues, even as other, more traditional markets have begun to slow. Scope of the Report: The worldwide market for Skin Ulcers Anti-Infectives is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Skin Ulcers Anti-Infectives in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East...
  • 皮膚潰瘍抗感染製品の世界市場：メーカー別、地域別、種類別、用途別、市場予測（～2024）
    GIR9101439 / GlobalInfoResearch / 2019年9月11日 / 本調査レポートは、皮膚潰瘍抗感染製品の世界市場について調べ、まとめました。種類別セグメントは、褥瘡、糖尿病性潰瘍、静脈性潰瘍、動脈性潰瘍等、用途別セグメントは、病院、診療所、その他等に区分しました。皮膚潰瘍抗感染製品の世界市場概観、メーカー動向、メーカー別皮膚潰瘍抗感染製品シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・皮膚潰瘍抗感染製品の市場概観 ・皮膚潰瘍抗感染製品の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・皮膚潰瘍抗感染製品の企業別販売動向、市場シェア、市場集中度、競争動向 ・皮膚潰瘍抗感染製品の世界市場規模 ・皮膚潰瘍抗感染製品の北米市場分析（アメリカ、カナダ、メキシコ等） ・皮膚潰瘍抗感染製品のアメリカ市場規模推移 ・皮膚潰瘍抗感染製品のカナダ市場規模推移 ・皮膚潰瘍抗感染製品のメキシコ市場規模推移 ・皮膚潰瘍抗感染製品のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...Wound Care Markets Volume I: Skin Ulcers, strong growth in newer technologies has been the main driver of increased revenues, even as other, more traditional markets have begun to slow. Scope of the Report: The worldwide market for Skin Ulcers Anti-Infectives Products is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Skin Ulcers Anti-Infectives Products in global market, especially in North America, Europe and Asia-Pacific, South America,...
  • 経口OTC鎮痛薬の世界市場：メーカー別、地域別、種類別、用途別、市場予測（～2024）
    GIR9101268 / GlobalInfoResearch / 2019年9月10日 / 本調査レポートは、経口OTC鎮痛薬の世界市場について調べ、まとめました。種類別セグメントは、アセトアミノフェン（タイレノール）、サリチル酸塩、非ステロイド性抗炎症薬（NSAID）等、用途別セグメントは、小売薬局、病院薬局、オンライン薬局等に区分しました。経口OTC鎮痛薬の世界市場概観、メーカー動向、メーカー別経口OTC鎮痛薬シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・経口OTC鎮痛薬の市場概観 ・経口OTC鎮痛薬の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・経口OTC鎮痛薬の企業別販売動向、市場シェア、市場集中度、競争動向 ・経口OTC鎮痛薬の世界市場規模 ・経口OTC鎮痛薬の北米市場分析（アメリカ、カナダ、メキシコ等） ・経口OTC鎮痛薬のアメリカ市場規模推移 ・経口OTC鎮痛薬のカナダ市場規模推移 ・経口OTC鎮痛薬のメキシコ市場規模推移 ・経口OTC鎮痛薬のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）... Scope of the Report: The worldwide market for Oral OTC Analgesics is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Oral OTC Analgesics in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. Market Segment by Manufacturers, this report covers Pfizer Bayer Novartis Johnson & Johnson GlaxoSmithKline Sanofi...
  • 経口製剤用医薬品添加剤の世界市場：メーカー別、地域別、種類別、用途別、市場予測（～2024）
    GIR9102925 / GlobalInfoResearch / 2019年9月23日 / 本調査レポートは、経口製剤用医薬品添加剤の世界市場について調べ、まとめました。種類別セグメントは、タブレット、カプセル等、用途別セグメントは、病院薬局、ドラッグストア、小売店、Eコマース等に区分しました。経口製剤用医薬品添加剤の世界市場概観、メーカー動向、メーカー別経口製剤用医薬品添加剤シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・経口製剤用医薬品添加剤の市場概観 ・経口製剤用医薬品添加剤の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・経口製剤用医薬品添加剤の企業別販売動向、市場シェア、市場集中度、競争動向 ・経口製剤用医薬品添加剤の世界市場規模 ・経口製剤用医薬品添加剤の北米市場分析（アメリカ、カナダ、メキシコ等） ・経口製剤用医薬品添加剤のアメリカ市場規模推移 ・経口製剤用医薬品添加剤のカナダ市場規模推移 ・経口製剤用医薬品添加剤のメキシコ市場規模推移 ・経口製剤用医薬品添加剤のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...Pharmaceutical excipients that deliver the full potential of your drug and improve patient compliance. Scope of the Report: The worldwide market for Pharmaceutical Excipients for Oral Formulations is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Pharmaceutical Excipients for Oral Formulations in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type...
  • OTC抗感染製品の世界市場：メーカー別、地域別、種類別、用途別、市場予測（～2024）
    GIR9102936 / GlobalInfoResearch / 2019年9月24日 / 本調査レポートは、OTC抗感染製品の世界市場について調べ、まとめました。種類別セグメントは、抗真菌剤、防腐剤、駆虫薬等、用途別セグメントは、病院薬局、ドラッグストア、小売店、Eコマース等に区分しました。OTC抗感染製品の世界市場概観、メーカー動向、メーカー別OTC抗感染製品シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・OTC抗感染製品の市場概観 ・OTC抗感染製品の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・OTC抗感染製品の企業別販売動向、市場シェア、市場集中度、競争動向 ・OTC抗感染製品の世界市場規模 ・OTC抗感染製品の北米市場分析（アメリカ、カナダ、メキシコ等） ・OTC抗感染製品のアメリカ市場規模推移 ・OTC抗感染製品のカナダ市場規模推移 ・OTC抗感染製品のメキシコ市場規模推移 ・OTC抗感染製品のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...Anti-infectives is a general term used to describe any medicine that is capable of inhibiting the spread of an infectious organism or by killing the infectious organism outright. Scope of the Report: The worldwide market for OTC Anti-Infective Products is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the OTC Anti-Infective Products in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa....

    • ◆H&Iグローバルリサーチのお客様（例）◆